AGENUS INC, Ten Percent Owner at MiNK Therapeutics, holds 21.77M shares in MiNK Therapeutics (Ticker: INKT). Most recently, AGENUS INC Bought $22,975 shares of MiNK Therapeutics on Oct 16, 2023 for an estimated value of 25.24K.
What is the percentage of profitable transactions made by AGENUS INC?
The percentage of profitable transactions made by AGENUS INC is 14%.
What is the average return per transaction made by AGENUS INC?
The average return per transaction made by AGENUS INC is -30.90%.
What stocks does AGENUS INC hold?
AGENUS INC holds: INKT stocks.
What was AGENUS INC’s latest transaction?
AGENUS INC latest transaction was an Informative Buy of $25.24K.
What was AGENUS INC's most profitable transaction?
AGENUS INC’s most profitable transaction was an Informative Buy of INKT stock on October 16, 2023. The return on the trade was 1.80%.
What is AGENUS INC's role in MiNK Therapeutics?
AGENUS INC's role in MiNK Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.